Form 4: USANA Health Sciences CEO Jim Brown Reports Stock Transactions
SEC Form 4 Filing
CEO Jim Brown reports transactions involving USANA Health Sciences stock, including the vesting and disposal of restricted stock units.
Summary
- Jim Brown, CEO & President of USANA Health Sciences Inc., reported transactions involving the company's stock on February 8, 2025.
- These transactions included the vesting of 2,828 and 11,800 restricted stock units, which convert into common stock.
- A portion of the shares obtained from the vesting of restricted stock units were then disposed of to cover tax obligations at a price of $30.65 per share.
- Following these transactions, Brown directly owns 20,716 shares of common stock and 53,186 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency to investors regarding insider activity.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading activities.
- Similar filings are made by executives at comparable companies like Herbalife Nutrition and Nu Skin Enterprises, detailing their stock transactions.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 02/08/2021 | Initial vesting date for 25% of the first set of Restricted Stock Units. |
| 02/08/2024 | Initial vesting date for 25% of the second set of Restricted Stock Units. |
| 02/08/2025 | Date of stock transactions, including vesting of restricted stock units and disposal of shares. |
| 02/11/2025 | Date of signature for the Form 4 filing. |
Keywords
USANA Health Sciences, Jim Brown, Stock Transactions, Restricted Stock Units, Form 4, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.